Lyell Immunopharma (LYEL) vs Nature's Sunshine Products (NATR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nature's Sunshine Products (NATR) has outperformed Lyell Immunopharma (LYEL) over the past year, losing 16.2% versus a loss of 51.9%. Over five years, NATR leads with a -18.2% price change compared with -96.7% for LYEL. Nature's Sunshine Products is the larger company by market cap ($222.5 million vs $216.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LYEL | NATR |
|---|---|---|
| Share price | $8.85 | $12.65 |
| Market cap | $216.75M | $222.50M |
| 1-day change | +0.63% | +0.60% |
| YTD return | -71.44% | -41.75% |
| 1-year return | -51.86% | -16.20% |
| 5-year return | -96.69% | -18.22% |
| P/E ratio (TTM) | — | 12.52 |
| Forward P/E | — | 10.28 |
| EPS (TTM) | $-12.86 | $1.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $45.00 | $28.14 |
| 52-week low | $8.21 | $12.31 |
| Distance from 52-week high | -80.34% | -55.06% |
| Analyst consensus | buy | none |
| Avg. price target upside | +328.26% | +141.20% |
| Average volume | 145.70K | 160.23K |
| Shares outstanding | 24.51M | 17.60M |
| Employees | 161 | 806 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NATR has outperformed LYEL by 35.7 percentage points over the past year.
About Lyell Immunopharma
LYEL stock →Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company's lead product candidate include rondecabtagene autoleucel, an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development, which is in pivotal PiNACLE trial in the 3L+ setting and in a Phase 1/2 clinical trial in the 2L setting, as well as a second pivotal trial, PiNACLE-H2H, which is a Phase 3 head-to-head CAR T cell therapy randomized controlled trial of ronde-cel for LBCL in the 2L setting for the treatment of large B-cell lymphoma; and LYL273, a GCC-targeted CAR T-cell product candidate enhanced with CD19 CAR expression and controlled cytokine release designed to improve CAR T-cell expansion, immune cell infiltration, and cancer cell killing in the hostile solid tumor microenvironment, which is in Phase 1 clinical trial for the treatment of refractory metastatic colorectal cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 161 employees
About Nature's Sunshine Products
NATR stock →Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees
LYEL vs NATR FAQ
Which is bigger, Lyell Immunopharma or Nature's Sunshine Products?
Nature's Sunshine Products (NATR) is larger, with a market capitalization of $222.50M compared with $216.75M for Lyell Immunopharma (LYEL).
Which stock has performed better over the past year, LYEL or NATR?
NATR returned -16.20% over the past 12 months, compared with -51.86% for LYEL (price return, excluding dividends). Past performance does not predict future results.
Are Lyell Immunopharma and Nature's Sunshine Products in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.